GI Dynamics, Inc
More than a slim chance
| Tony Featherstone
Featherstone | By targeting obesity and diabetes, GI Dynamics’ new product could have huge potential.
Humble devices ace drugs
| Tony Featherstone
Featherstone | Medical-device makers, with their simpler technology and shorter path to market, can trump their flashy drug company rivals.
There’s value in biotechs
| Tony Featherstone
Featherstone | Some promising biotech stocks are emerging for investors comfortable with higher-risk microcaps as smaller companies move towards commercialisation.
advertising
sponsored links